Question of the Day – Wednesday April 26, 2017
Question: What is the typical clinical progression of the phenytoin and fosphenytoin related “purple-glove syndrome”?
Question of the Day – Tuesday April 25, 2017
Question: A blue color tinge to the vision has been reported in conjunction with which drug sometimes prescribed for the treatment of erectile dysfunction?
Question of the Day – Monday April 24, 2017
Question: What is the Federal act that governs the speed of the regulatory review process for new therapeutic agents?
Question of the Day – Thursday April 20, 2017
Question: What are the MRI findings consistent with severe methanol toxicity?
Question of the Day – Wednesday April 19, 2017
Question: Hereditary angioedema may be clinically confused with severe drug related reactions in some circumstances. What is hereditary angioedema and what is the cause for hereditary angioedema?
Question of the Day – Tuesday April 18, 2017
Question: What is so-called “NSAID colopathy”?
Question of the Day – Monday April 17, 2017
Question: What is the common name for the chemical 2-chlorovinyldichloroarsine?
Question of the Day – Friday April 14, 2017
Question: What characterizes the clinical findings associated with tick paralysis?
